CACrown ArchivesThe cinema collection
Menu
Research dossier · Science & Nature

Maklamicin

chemical compound

Specimen drawers, botanical folios and brass scientific instruments under study light
Science and natureInterpretive dossier study · Crown Archives visual atlas
Record originEnglish Wikipedia
Text licenseCC BY-SA 4.0
Source revisionDec 21, 2025
Entity authorityQ27136349
Source-derived summary

Maklamicin is a spirotetronate-class polyketide natural product. Isolated from Micromonospora sp. GMKU326 found in the root of Maklam phueak, it displays antibiotic activity against Gram-positive bacterial strains Micrococcus luteus, Bacillus subtilis, Bacillius cereus, Staphylococcus aureus, and Enterococcus faecalis.

Biosynthesis

Maklamicin arises from a type I modular polyketide synthase (PKS) system. The structure of its polyketide chain extension has been shown to contain thirteen discrete PKS modules (a loading module and twelve extension modules).

After passing through the extension domains the linear polyketide precursor to Maklamicin undergoes an intramolecular Diels-Alder reaction (IMDA) to form its trans-decalin motif. 1,3-bisphosphoglycerate is converted to glyceryl S-ACP and condenses onto the decalin-bearing polyketide intermediate to furnish an intermediate containing the premature tetronate moiety. This intermediate then acetylated and subsequently dehydrated to form the exocyclic olefin of the mature tetronate moiety. The intermediate, now containing both the tetronate and trans-decalin motifs of Maklamicin is then systematically reduced to afford a diene. A second IMDA then occurs between the tetronate and newly formed dienophile to yield the ultimate intermediate which is oxidized to afford Maklamicin.

Editorial summary

Begin with the source’s own compact description: “Maklamicin” is chemical compound. The dossier treats that line as a proposition to test through Maklamicin, chemical and compound, not as a finished interpretation.

Editorial reviewUseful for establishing the present vocabulary of the subject while preserving a route back to the evidence on which that vocabulary rests. The current 178-word lead offers orientation but no explicit four-digit date, so chronology should not be assumed. The selected authority fields contribute no independent date. For this dossier, Maklamicin, chemical and compound is the immediate research focus.
Editorial analysis

Why this record matters

The phrase “chemical compound” supplies a clear boundary for inquiry. It also exposes the unanswered questions: who defined that boundary, when it became stable and which sources sit outside it.

Evidence profile

Stable identifiers, scientific names and standards terminology offer the best bridge between this overview and specialist evidence. The source revision retrieved here is dated Dec 21, 2025. The linked authority identifier is Q27136349. None of the 0 selected statements returned an explicit reference.

Critical limits

Scientific names, classifications and consensus can change while older terminology persists in catalogues and historical literature. The lead is largely declarative, so disagreement and counter-evidence require a deliberate search beyond the opening account. Authority statements aid reconciliation but still require their own references, qualifiers and ranks to be checked.

How to read it

Check terminology, classification and the date of the cited evidence. Scientific names and technical consensus can change while older records retain historical value.

Best used for
  • Current terminology
  • Classification context
  • Finding cited technical literature
Verify next

Primary datasets, specimen catalogues, standards bodies and the most recent peer-reviewed literature.

Three-step research path

  1. Establish the record: confirm the title “Maklamicin”, its source revision and the description used here.
  2. Expand the search: follow Maklamicin primary sources, Maklamicin archive and Maklamicin research across catalogues and specialist indexes.
  3. Test the account: compare the strongest cited source with the responsible institution’s current record and note any disagreement.

Questions for further research

  1. Which source most directly establishes the central claim about “Maklamicin”?
  2. Has classification or technical consensus changed since the cited source?
  3. Is the terminology current, historical or disputed?
Subject index

Search terms from this dossier

Source & attribution

This entry incorporates text from Maklamicin” on English Wikipedia. Contributors are listed in the page history. Text is available under the Creative Commons Attribution-ShareAlike 4.0 License. Selected authority identifiers and statements are retrieved from Wikidata under CC0; their references and qualifiers remain part of the verification path.